The 20 Best Diabetic Retinopathy Doctors Near Me in Glen Burnie, MD

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Bressler is board certified in American Board Of Ophthalmology.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Elite provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Paulus is board certified in American Board Of Ophthalmology.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy. Dr. Bressler is board certified in American Board Of Ophthalmology.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy. Dr. Campochiaro is board certified in American Board Of Ophthalmology.

Elia J. Duh, M.D., is the G. Edward and G. Britton Durell Professor of Ophthalmology at the Wilmer Eye Institute. He has a joint appointment in the Department of Chemical and Biomolecular Engineering, The Whiting School of Engineering. He specializes in diseases of the retina, including diabetic retinopathy and age-related macular degeneration. In addition to his clinical practice, Dr. Duh actively researches the molecular mechanisms underlying diabetic retinopathy and macular degeneration, particularly the process of ocular neovascularization and excessive retinal vascular permeability. His research has helped determine the role of the major antioxidant regulator, Nrf2, in retinal diseases, and also connected Nrf2 to lifespan. His work has also provided insights into the involvement of the eye in COVID-19. Dr. Duh’s interest in developing new treatments for retinal diseases includes nanomedicine approaches for targeted drug delivery to the eye. Dr. Duh graduated summa cum laude from Yale University and obtained his medical degree from Harvard Medical School. He completed his ophthalmology residency and medical retina fellowship at the Wilmer Eye Institute. He was elected to the American Society of Clinical Investigation in 2016. Dr. Duh is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Vitrectomy. Dr. Duh is board certified in American Board Of Ophthalmology.

Akrit Sodhi, M.D, Ph.D., is an Associate Professor of Ophthalmology at the Wilmer Eye Institute and holds the Branna and Irving Sisenwein Professorship in Ophthalmology. Dr. Sodhi specializes in the medical and surgical management of complex vitreoretinal diseases. Dr. Sodhi was trained at the University of California at Los Angeles (UCLA), the University of California at Davis, and the National Institutes of Health. After obtaining his M.D. and Ph.D., he interned at Sinai Hospital in Baltimore and completed his Ophthalmology Residency training at the Wilmer Eye Institute at Johns Hopkins in 2008. He then pursued a fellowship in vitreoretinal surgery at Wilmer where he also served as the Assistant Chief of Service (Chief Resident). Dr. Sodhi joined the faculty of the Retina Division at Wilmer in 2010. His research interests, currently sponsored by grants from the National Eye Institute, include the examination of the role of hypoxia inducible factor (HIF) and HIF-regulated genes in ocular diseases, including diabetic eye disease, age-related macular degeneration, sickle cell retinopathy, retinal vein occlusions, and uveal melanoma. Dr. Sodhi's lab has identified novel therapeutic targets for the treatment of these vision-threatening diseases. Dr. Sodhi is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Late-Onset Retinal Degeneration. Dr. Sodhi is board certified in American Board Of Ophthalmology.

Kristin Flammer is an Endocrinologist practicing medicine in Glen Burnie, Maryland. Dr. Flammer is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Nodule, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

Kathleen Prendergast is an Endocrinologist practicing medicine in Glen Burnie, Maryland. Dr. Prendergast is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Neuropathy, Maturity Onset Diabetes of the Young, and Hypothyroidism.

Michael Elman is an Ophthalmologist practicing medicine in Rosedale, Maryland. Dr. Elman is rated as an Elite provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Vein Occlusion, and Vitrectomy. Dr. Elman is currently accepting new patients.

Tatyana Sergeyeva is an Endocrinologist practicing medicine in Glen Burnie, Maryland. Dr. Sergeyeva is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Hypothyroidism, Toxic Nodular Goiter, and Obesity in Children.

Fernando Arevalo is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Arevalo is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

Peter L. Gehlbach, M.D., Ph.D. is the J. Willard Marriott, Jr. Professor of Ophthalmology with joint appointment in the Department of Electrical and Computer Engineering, The Whiting School of Engineering. A member of the Wilmer faculty since 2000, he was recruited by a national search to become the inaugural Maumenee Scholar at Johns Hopkins University School of Medicine. His clinical practice is composed of international, national, and regional patient populations with the most complex retinal disease. An expert vitreoretinal surgeon, Dr. Gehlbach has been a leader in performing and teaching complex surgical cases that require coordination with multiple ophthalmological specialists. His research interests include cutting-edge surgical approaches to patients with retinal disease and the development of novel surgical tools and approaches to retinal microsurgery. Dr. Gehlbach’s work has been supported by multiple NIH grants and prestigious foundations with research published in numerous peer-reviewed journals and presented at ophthalmology conferences around the world. The founding director of the former Wilmer Gene Therapy Vector Center, he has served as the director of the Wilmer Echography Center as well as the Retina Fellowship Training Program at Johns Hopkins. He holds multiple patents in both the U.S. and abroad. Dr. Gehlbach received his B.A. and M.D. degrees from the University of Vermont, and his Ph.D. in cell and integrative physiology from the University of Minnesota. He completed an internship and residency training in general surgery at the University of Health Sciences, Chicago Medical School. His ophthalmology residency was at Washington University in St. Louis, where he also completed a fellowship in protein chemistry. He completed a medical and surgical retina fellowship at the Casey Eye Institute in Portland. Dr. Gehlbach is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Vitrectomy. Dr. Gehlbach is board certified in American Board Of Ophthalmology.

Mira M. Sachdeva, M.D., Ph.D. specializes in the medical and surgical management of diseases of the retina, including diabetic retinopathy, macular degeneration, retinal vascular occlusions, retinal detachments, macular holes, and epiretinal membranes. Her research efforts are directed towards developing new treatments to prevent or reverse the retinal neurodegeneration and vision loss that occurs in patients with diabetes. Dr. Sachdeva’s ultimate goal is to identify strategies for neuroprotection that are broadly applicable to other conditions in which the retina is irreversibly damaged, including macular degeneration and retinal detachment. Dr. Sachdeva received her medical degree from the University of Pennsylvania medical school. She completed her residency at the Wilmer Eye Institute in 2014. Thereafter, she completed a fellowship at the Massachusetts Ear and Eye Infirmary. Dr. Sachdeva is currently a Wilmer Rising Professor in Ophthalmology. Videos Dr. SachdevaOphthalmology Recent News Articles and Media Coverage Bridging the Gap, Wilmer Magazine (July 2019). Dr. Sachdeva is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vitrectomy. Dr. Sachdeva is board certified in American Board Of Ophthalmology.

Adrienne W. Scott, M.D, is a retina specialist and the Fred M. Leader Family Retina Professor of ophthalmology at the Wilmer Eye Institute's locations in Baltimore and Bel Air, Maryland. Dr. Scott treats patients across the spectrum of vitreoretinal medical and surgical diseases, including macular degeneration, diabetic retinopathy, retinal detachments and more. Dr. Scott received her doctor of medicine degree from Drexel University College of Medicine in Philadelphia, Pennsylvania and completed her ophthalmology residency at the Duke University Eye Center. During her residency, Dr. Scott received the Ocular Innovation Award, the K. Alexander Dastgheib Eye Surgery Award and the Edward K. Isbey, Jr. M.D. Award for clinical excellence. She remained at the Duke Eye Center to complete her two-year fellowship training in vitreoretinal surgery prior to joining the Wilmer faculty. Dr. Scott is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy. Dr. Scott is board certified in American Board Of Ophthalmology.

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy. Dr. Sarkar is board certified in American Board Of Internal Medicine.

Paul Tarantino is an Ophthalmologist practicing medicine in Glen Burnie, Maryland. Dr. Tarantino is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Cataract, Blepharitis, and Diabetic Retinopathy.

Arturo Betancourt is an Ophthalmologist practicing medicine in Glen Burnie, Maryland. Dr. Betancourt is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Cataract, Dry Eye Syndrome, Glaucoma, Blepharitis, and Cataract Removal.

Brad Spagnolo is an Ophthalmologist practicing medicine in Glen Burnie, Maryland. Dr. Spagnolo is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Cataract, Dry Eye Syndrome, Subconjunctival Hemorrhage, Meibomianitis, and Cataract Removal.

Vincent Notarangelo is an Ophthalmologist practicing medicine in Brooklyn, Maryland. Dr. Notarangelo is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Cataract, Orbital Cellulitis, and Dry Eye Syndrome.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy. Dr. Handa is board certified in American Board Of Ophthalmology.